Alternatives to Khartis Therapeutics, Inc.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Advancing next-generation mRNA medicines.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

Developing first-in-class oral therapy for BK polyomavirus infections.

Immunotherapy company targeting oncology and autoimmune diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Scalable, one-time curative in-vivo gene editing therapies.

Developing novel male contraceptives.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Advancing targeted alpha therapies.

A biopharmaceutical company focused on drug discovery and development.

AI-enabled technology for cell biology research and biopharma development.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Biopharmaceutical company developing innovative therapies for sepsis and intensive care.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Accelerating medicine for the people who need it, prescribe it, and create it.

Clinical-stage biotech company developing transformative cytokine therapies.

Developing novel therapeutics for inflammatory and hypoxic diseases.

Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals.

Venture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Developing an automated platform for liquid biopsy sample preparation.

Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.